Wellness product provider moves forward with acquisition of high-value product development and production company “The Plant”: NutraNomics Inc. (ticker symbol: NNRX)

  • Growing global provider of wellness products through acquisitions.
  • Pending acquisition of DHS Development, Inc. dba The Plant for Premium Quality Botanical Wellness Products.
  • Plans to provide sourcing, mining and processing, product development, contract manufacturing and contract packaging.
  • Acquisition facility conveniently located just outside of Los Angeles in a jurisdiction with ZERO manufacturing tax.
  • Acquisition pending, expected to close in February.

NutraNomics Inc. (OTC: NNRX) was incorporated in 2007 and quickly grew to global success with its outstanding reputation for supporting individual health featuring its own nutraceutical products. Today, NNRX is more committed than ever to serving and supporting the alternative health needs of all individuals. the NNRX mission is to provide products for organic health needs and health solutions in healing is focused on expanding market share through acquisitions and alliances which plays a pivotal role in driving the growth of companies that provide specialized product solutions.

All products NNRX The features are designed to provide every customer with 100% organic, highly potent and intensely acute alternative options to provide healing benefits in all markets. Targets include: alliances, acquisitions and continued supply of our high quality blends with proven trade secrets in curing heart disease, cancer, type 2 diabetes, obesity and obesity. arthritis, all of which are among the most common, costly and preventable. health problems.

  • Pending acquisition of DHS Development, Inc. dba The Plant for Botanical Wellness Product development, production and service

January 25and NNRX provided advice related to its current pending acquisition. NNRX has entered into a binding letter of intent with DHS Development Inc. dba The Plant, of Desert Hot Springs, CA. (www.theplantlabs.com), to acquire the organization’s assets, intellectual property and key personnel. Plant managers and top managers are an essential component of the NNRX strategic vision for growth and essential to its path to success in a changing industry.

NNRX capital investment will focus on improving equipment and facilities with respect to building manufacturing and cultivation infrastructure to meet existing and pending wholesale agreements and support production of premium botanical wellness products such as Cured and Live Concentrates, Raw, Distillates, Pre-Rolls, Capsules, Gummies, Tablets, Vape Cartridges, Topicals, Flowers, as well as contract packaging. Pending the completion of the acquisition of The Plant, NNRX Commits up to $1 million in leveraged interim capital for manufacturing assets needed to meet immediate customer product demand.

Regarding the acquisition, Jonathan Bishop, CEO of NNRX, said, “Through our strategic capital investment in critical elements of our manufacturing and cultivation operations, we are committed to the principles of optimum quality and cost effectiveness. Our smart verticalization plan not only establishes a solid foundation on which to produce superior products for our valued customers, but also allows us to scale our 27,000 square foot production facility into other areas of unique product differentiation. in conjunction with the addition of our 30,000 square feet. . State-of-the-art cultivation operation.

The plant’s new flagship facility was designed and built to provide a full range of services, including a variety of extraction methods and innovative post-processing options under one roof. The factory provides a true one-stop-shop for all manufacturing and product development needs of its customers. Not only does this maximize time and cost efficiency by having all of these services in one facility, The Plant is also conveniently located just outside of LA and in a jurisdiction with ZERO manufacturing tax.

The acquisition of The Plant will NNRX to offer custom extracts, bulk oil, private label or product development support, to become any customer’s preferred manufacturing partner.

Current factory services include:

  • Supply
  • Extraction & Processing
  • Product development
  • Contract Manufacturing
  • Contract packaging

Further details regarding the terms of the acquisition will be disclosed after the official closing scheduled for mid-February. In the meantime, the company’s two management teams will work together to support The Plant’s growth efforts and onboard current and additional customers.

NNRX CEO Jonathan Bishop also said, “This is an exciting milestone and opportunity for NutraNomics and represents the first of future mergers and acquisitions to come. We believe The Plant and its principals are key anchors in our efforts to further the NutraNomics mission with superior processing, product diversity and R&D intelligence. As such, this initial acquisition is a methodical and responsible move in our quest to acquire resources in the seed, science, processing and distribution model that NutraNomics continues to target.

For more information about NutraNomics Inc. (OTC: NNRX) visit: https://nutranomics.com.

Products mentioned are THC-free and/or Farm Bill 2018 compliant.


FrontPageStocks/CorporateAds.com (CA) is a third party publisher and news distribution service provider. FPS/CA is NOT affiliated in any way with any company mentioned herein. FPS/CA is a news delivery solutions provider and is NOT a registered broker/dealer/analyst/advisor, does not hold any investment license and may NOT sell, offer to sell or offer to buy any securities . FPS/CA’s market updates, news alerts and company profiles are NOT a solicitation or recommendation to buy, sell or hold any securities. The content of this release is intended for informational purposes only and should NEVER be construed or construed as research material. All readers are strongly urged to conduct their own research and due diligence and to consult with a licensed financial professional before considering any level of equity investment. All material included here is republished content and details that have been previously released by the companies mentioned in this release or the opinion of the author. FPS/CA is not responsible for the investment decisions of its readers or subscribers. Investors are warned that they may lose some or all of their investment when investing in stocks. FPS/CA was compensated $500 by the company for publishing this article.

Disclaimer/Safe Harbor:

These press releases and postings may contain forward-looking statements within the meaning of the Securities Litigation Reform Act. Statements reflect the Company’s current beliefs regarding future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, failure to meet deadlines or performance requirements of the companies’ contracts, the companies’ liquidity condition, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive prices. In light of these uncertainties, the forward-looking events discussed in this press release may not occur.

Media Contact
E-mail: Send an email
Call: +1 408-495-3142
Address:605 Portland Avenue Unit 154
City: Gladstone
State: OR 97027
Country: United States
Website: www.nutranomics.com


Comments are closed.